Category Archives: Pour les ophtalmologistes
ESCRS Launches Online IOL Calculator
Oct 20th, 2022
The developers’ goal was to create a free online tool that helps ophthalmologists aggregate the major online IOL calculators in one site, allowing them to get multiple results with only one data entry session. “This will reduce typing mistakes, provide a better view, and allow users to compare results, eventually helping to get better refractive […]
The 14th Annual Congress on Controversies in Ophthalmology
Oct 20th, 2022
The 14th Annual Congress on Controversies in Ophthalmology: (COPHy) taking place in Lisbon, Portugal, March 24-25, 2023. Date: March 24- 25, 2023 Location: Lisbon, Portugal The great success of the previous COPHy Congresses, held across Europe in Prague, Barcelona, Istanbul, Budapest, Lisbon, Sorrento, Warsaw, Madrid, Athens and Dublin as well as the enthusiastic feedback received […]
Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis.
Oct 20th, 2022
We are pleased to share with you the Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis. These Canadian JIA-associated uveitis guidelines were developed by a working group of 14 pediatric rheumatologists, 6 ophthalmologists, 2 methodologists and 3 caregiver/patient representatives using a GRADE-Adolopment approach applied to the 2019 ACR JIA-Associated […]
61st Annual Ophthalmology Update Walter Wright Symposium
Oct 18th, 2022
Title: Walter Wright 20/20+2: Cornea, Anterior Segment and Refractive Surgery Date: December 2nd – 3rd Location: Metro Toronto Convention Centre, Toronto, ON Guest Speakers: Drs. Anthony J. Aldave, James Chodosh, Sadeer B. Hannush, Carol L. Karp, Terry Kim, Christopher J. Rapuano, Elmer Tu, Stephanie Watson This year’s Walter Wright program will showcase an exciting and relevant presentation […]
DOVS RESIDENT TEACHING – IN PERSON SESSION – Management of Scleritis: 2022 and Beyond AND Retinal Vasculitis: Diagnosis and Management
Oct 18th, 2022
Date: Friday October 21, 2022 Time: 8:45 AM – 12:00 PM Location: Kensington Gardens – 45 Brunswick Ave., Toronto, M5S 3M3 *Please arrive early to perform at Rapid Antigen Test at the door, or you may perform one at home prior to arriving and take a date/time-stamped picture of your result* Room: Multi-purpose Room Topic: […]
VPP DOVS GRAND ROUNDS – Top Five Commonly Made Mistakes in the Management of Uveitis
Oct 18th, 2022
Date: Friday October 21, 2022 Time: 7:30 AM – 8:30 AM Topic: Top Five Commonly Made Mistakes in the Management of Uveitis Speaker: Dr. Quan Dong Nguyen Zoom Link – Register in advance for this webinar: After registering, you will receive a confirmation email containing information about joining the webinar. OBJECTIVES: 1. To present and discuss the […]
DOVS CORNEA ROUNDS – Ocular Surface Disease: Medical Optimization and Surgical Interventions Part 2
Oct 18th, 2022
Date: Thursday October 20, 2022 Time: 5:00 PM – 6:00 PM Topic: Ocular Surface Disease: Medical Optimization and Surgical Interventions Part 2 Speakers: Drs. Mimouni, Trinh, Din, Chan, AlShaker Zoom Link – Register in advance for this webinar: After registering, you will receive a confirmation email containing information about joining the webinar. OBJECTIVES: 1. Review Mackie […]
CJO: October 2022 Issue Highlights
Oct 18th, 2022
The October 2022 CJO is now available online. Here are some of the highlights: Resident Perspectives + visual abstract: Our amazing team of residents have summarized 6 articles with a focus on what’s most relevant to ophthalmology learners here in Canada and around the globe, including the article featured in our October visual abstract, Macular […]
Énoncé de principe conjoint de la Société canadienne d’ophtalmologie (SCO) sur les médicaments biosimilaires
Oct 17th, 2022
octobre 2022 Les médicaments biologiques biosimilaires (biosimilaires*) ont fait leur apparition sur le marché canadien en 2009. Le premier biosimilaire ophtalmique pour injection intravitréenne devrait être lancé au Canada à la fin de l’automne 2022. Avec ce lancement, on prévoit que l’utilisation de biosimilaires au Canada augmentera rapidement. Lisez la déclaration de position complète ici.